Iranian scientist claims to have invented drug for COVID-19 treatment
Masoud Soleimani says medicine can be used to treat coronavirus patients in three phases
Masoud Soleimani says medicine can be used to treat coronavirus patients in three phases. PHOTO: IRAN FRONT PAGE
As the novel coronavirus continues to wreak havoc across the world, an Iranian scientist has claimed that he has invented a drug using stem cells for COVID-19 treatment.
Masoud Soleimani, the Iranian stem cell scientist who has been recently released from the US prison, says many doctors had used his drug to treat coronavirus patients and found it effective against the highly contagious disease, Iran Front Page reported on Saturday.
He says the medicine can be used to treat coronavirus patients in three phases in a period of three to six days.
Russia claims it produces drug to treat COVID-19
“The important point in the development of the coronavirus medicine is that clinical tests are still being conducted on it, and we hope we will achieve better results in the coming days,” he told the Iranian publication.
“Final and complementary research work is underway for final approval of the drug,” the scientist added.
Iran is among the few countries most affected by the pandemic. On Friday, the health ministry reported a death toll of 2,378 and total confirmed infections at 32,332 in the country.
Earlier in the day, President Hassan Rouhani said the country's health infrastructure is strong and ready to cope with a possible escalation in coronavirus cases.
This article originally appeared in Iran Front Page
Masoud Soleimani, the Iranian stem cell scientist who has been recently released from the US prison, says many doctors had used his drug to treat coronavirus patients and found it effective against the highly contagious disease, Iran Front Page reported on Saturday.
He says the medicine can be used to treat coronavirus patients in three phases in a period of three to six days.
Russia claims it produces drug to treat COVID-19
“The important point in the development of the coronavirus medicine is that clinical tests are still being conducted on it, and we hope we will achieve better results in the coming days,” he told the Iranian publication.
“Final and complementary research work is underway for final approval of the drug,” the scientist added.
Iran is among the few countries most affected by the pandemic. On Friday, the health ministry reported a death toll of 2,378 and total confirmed infections at 32,332 in the country.
Earlier in the day, President Hassan Rouhani said the country's health infrastructure is strong and ready to cope with a possible escalation in coronavirus cases.
This article originally appeared in Iran Front Page